Global Body Contouring Devices Market

Body Contouring Devices Market Size, Share, Growth Analysis, By Product Type (Non-Invasive Devices, Minimally Invasive Devices), By Application (Fat Reduction, Skin Tightening), By End-User (Hospitals, Clinics), By Region - Industry Forecast 2025-2032

Report ID: SQSG35B2021 | Region: Global | Published Date: February, 2024
Pages: 242 | Tables: 63 | Figures: 75

Body Contouring Devices Market Competitive Landscape

Many of these firms are quickly choosing to expand geographically, collaborate strategically, and form alliances through mergers and acquisitions in developing and prosperous regions. Evolve Tone was certified by Health Canada and given to InMode Ltd. in June 2021. With this approval, Evolve platform will become Canada's only three distinct body remodelling technologies Tite, Trim, and Tone all in one hands-free device. The following are a few of the leading companies in the body-contouring device market.

Body Contouring Devices Market Top Player’s Company Profiles

  • Cynosure, Inc. (USA) 
  • Alma Lasers Ltd. (Israel) 
  • Syneron Medical Ltd. (Israel) 
  • Bausch Health Companies Inc. (Canada) 
  • Lumenis Ltd. (Israel) 
  • Cutera, Inc. (USA) 
  • Hologic, Inc. (USA) 
  • InMode Ltd. (Israel) 
  • Sciton, Inc. (USA) 
  • Venus Concept Inc. (Canada) 
  • Fotona d.o.o. (Slovenia) 
  • Solta Medical, Inc. (USA) 
  • BTL Industries Inc. (USA) 
  • Lutronic Corporation (South Korea) 
  • Zimmer MedizinSysteme GmbH (Germany) 
  • Erchonia Corporation (USA) 
  • Candela Corporation (USA) 
  • Revance Therapeutics, Inc. (USA) 
  • Merz Pharma GmbH & Co. KGaA (Germany) 
  • Aerolase Corporation (USA) 

Body Contouring Devices Market Recent Development

  • In June 2021, people aged 18 and older who weighed more than 1.9 billion were overweight. Of these, nearly 650 million were obese; of people 18 and older, 39% were overweight and 13% were obese in the same year. The majority of people on Earth reside in nations where being overweight or obese kills more people than being underweight.
  • In May 2021, Allergan aesthetic expanded the company's body contouring portfolio by announcing the acquisition of soliton and its newly launched RAP device.
  • In May 2022, The EON Smarter Body Contouring device for noninvasive laser lipolysis of adipose tissue of the flanks introduced by Dominion Aesthetic Technologies received clearance from United States Food and Drug Administration clearance.
  • In April 2022, VLCC announced the launch of a new non-invasive body contouring and slimming treatment in Oman, which uses United States Food and Drug Administration-approved laser technology to remove excess fat from the body without any surgical procedure.
  • In May 2021, Allergan Aesthetics and Soliton announced an agreement under which Allergan Aesthetics will acquire Soliton and RESONICTM, its Rapid Acoustic Pulse device, the U.S. Food and Drug Administration (FDA) 510(k) approved is a non-invasive treatment for the short-term advancement in the appearance of cellulite. This acquisition will expand and complements Allergan Aesthetics' Body Contouring treatment portfolio, which includes CoolSculpting Elite
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

The body contouring devices market is expected to grow at a compound annual growth rate of 14.3% from 2023 to 2031.

The FDA has not cleared any dermal filler, including silicone, for injection in body contouring procedures.

Global Body Contouring Devices Market size was valued at USD 1.33 billion in 2022 and is poised to grow from USD 1.52 billion in 2023 to USD 4.43 billion by 2031, growing at a CAGR of 14.3% during the forecast period (2024-2031). 

Many of these firms are quickly choosing to expand geographically, collaborate strategically, and form alliances through mergers and acquisitions in developing and prosperous regions. Evolve Tone was certified by Health Canada and given to InMode Ltd. in June 2021. With this approval, Evolve platform will become Canada's only three distinct body remodelling technologies Tite, Trim, and Tone all in one hands-free device. The following are a few of the leading companies in the body-contouring device market. 'Cynosure, Inc. (USA) ', 'Alma Lasers Ltd. (Israel) ', 'Syneron Medical Ltd. (Israel) ', 'Bausch Health Companies Inc. (Canada) ', 'Lumenis Ltd. (Israel) ', 'Cutera, Inc. (USA) ', 'Hologic, Inc. (USA) ', 'InMode Ltd. (Israel) ', 'Sciton, Inc. (USA) ', 'Venus Concept Inc. (Canada) ', 'Fotona d.o.o. (Slovenia) ', 'Solta Medical, Inc. (USA) ', 'BTL Industries Inc. (USA) ', 'Lutronic Corporation (South Korea) ', 'Zimmer MedizinSysteme GmbH (Germany) ', 'Erchonia Corporation (USA) ', 'Candela Corporation (USA) ', 'Revance Therapeutics, Inc. (USA) ', 'Merz Pharma GmbH & Co. KGaA (Germany) ', 'Aerolase Corporation (USA) '

One of the key factors expected to accelerate the growth and demand for body contouring devices is the increase in awareness of noninvasive and minimally invasive body contouring techniques. Over the forecast period of 2021 to 2028, it is also expected that increased safety brought about by minimally invasive and aesthetic procedures will help drive the expansion of the global market. Additionally, the launch of cutting-edge technologies and an increase in obesity rates are projected to boost the market's expansion. Additionally, among the important factors expected to propel the growth of the body contouring devices market are the quick advancements in aesthetics technology and the rise in awareness of body contouring.

The popularity of non-invasive and minimally invasive technologies may be attributed to the comparatively inexpensive cost of the operation and its few negative effects. As these procedures satisfy the patient's need for a rapid recovery and minimal stress, they raise demand, which benefits the manufacturers. The usage of minimally invasive surgery methods, which are already used in a number of body contouring specializations, is expected to rise over the projected period. For instance, the US Food and Drug Administration in July 2021 approved Allergan's CoolTone, a New Body-Contouring Device with Magnetic Muscle Stimulation (MMS). Additionally, it is projected that the adoption of minimally invasive procedures and the global rise in obesity would accelerate the segment's growth throughout the projection period.

In 2021, North America held the greatest revenue share of 35.8% in the global market for body contouring devices. Throughout the forecast period, the segment is expected to display a considerable CAGR. This is attributable to a growing elderly population, a robust healthcare system, clear reimbursement guidelines, the presence of significant market participants, and improvements in aesthetic body reshaping operations. Additionally, factors like high acceptance and openness toward body contouring treatments and a rising pool of consumers who are concerned with their looks are projected to drive the noninvasive body contouring market in North America.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Hi-Tech Medical Devices Market
Buy Now GET FREE SAMPLE
Medical Devices Market
Buy Now GET FREE SAMPLE
Wearable Medical Devices Market
Buy Now GET FREE SAMPLE
Neurology Devices Market
Buy Now GET FREE SAMPLE
Occlusion Devices Market
Buy Now GET FREE SAMPLE
Craniomaxillofacial Devices Market
Buy Now GET FREE SAMPLE
Neurovascular Devices Market
Buy Now GET FREE SAMPLE
3D Printing Medical Devices Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Body Contouring Devices Market

Report ID: SQSG35B2021

$5,300
BUY NOW GET FREE SAMPLE